Effects of Lomitapide on Carotid and Aortic Atherosclerosis
NCT02399852 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2017-12-15
Summary
Study to assess changes in carotid and aortic atherosclerosis in patients being treated with lomitapide.
Conditions
- Homozygous Familial Hypercholesterolemia
Interventions
- DRUG
-
Lomitapide
Sponsors & Collaborators
-
Aegerion Pharmaceuticals, Inc.
lead INDUSTRY
Principal Investigators
-
Qing Chang, MD · Aegerion Pharmaceuticals, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2018-12-31
- Completion
- 2021-12-31
More Related Trials
-
Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
NCT01952392 ·Status: COMPLETED
-
COMT on Aspirin Platelets Effects (CAPE)
NCT03433586 ·Status: UNKNOWN ·Phase: PHASE4
-
Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement
NCT00465218 ·Status: COMPLETED
-
Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction
NCT02525081 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects
NCT01311622 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects
NCT02526888 ·Status: COMPLETED ·Phase: PHASE1
-
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
NCT07125417 ·Status: RECRUITING ·Phase: PHASE4
-
Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care
NCT04099238 ·Status: COMPLETED
-
START-Register: Survey on Anticoagulated Patients Register
NCT02219984 ·Status: RECRUITING
-
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
NCT01225562 ·Status: COMPLETED ·Phase: PHASE3
-
Reversal of the Anti-platelet Effects of Ticagrelor
NCT02383771 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation
NCT02082548 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
NCT01023360 ·Status: UNKNOWN ·Phase: PHASE4
-
Replication of the ROCKET-AF Anticoagulant Trial in Healthcare Claims Data
NCT04593056 ·Status: COMPLETED
-
Aspirin Responsiveness in Women With Coronary Artery Disease
NCT01406990 ·Status: COMPLETED
-
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
NCT01395550 ·Status: COMPLETED
-
Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
NCT05986968 ·Status: RECRUITING ·Phase: NA
-
Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
NCT03005704 ·Status: UNKNOWN ·Phase: NA
-
Low Dose Aspirin Studied With the AggreGuide
NCT01603966 ·Status: COMPLETED
-
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease
NCT04132791 ·Status: TERMINATED ·Phase: NA
-
Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
NCT00822536 ·Status: COMPLETED ·Phase: PHASE4
-
Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA
NCT06591312 ·Status: RECRUITING ·Phase: PHASE3
-
ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures
NCT00593762 ·Status: SUSPENDED